Champions Oncology Investor Relations Material
Latest events
Q3 2024
Champions Oncology
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Champions Oncology Inc
Access all reports
Champions Oncology Inc offers products and services to the pharmaceutical and biotechnology industry that assist companies in developing new treatment for cancer patients. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also provides Translational Oncology Solutions that utilizes its Tumorgraft Technology Platform to assist pharmaceutical and biotechnology companies with their drug development process.
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States